Pfizer's API business revenue falls 13% on lower international sales

By Gareth Macdonald contact

- Last updated on GMT


Related tags: Revenue, Pfizer

Revenue generated by Pfizer’s API and contracting business fell in the second quarter.

The US drug firm’s contract manufacturing business – Pfizer CentreOne - generated $171m (€144m) in the three months to the end of June, down 13% on the year earlier quarter.

In the US, CentreOne – which is a unit of Pfizer’s Essential Health division - generated revenue of $132m, which is up $1m from the contribution in Q2 last year. In contrast, in international markets, the unit brought in $39m, down 39%.

The decline continues the trend seen in Q1 when the CentreOne unit’s revenue fell 8% to $182m as a result of lower international sales.

Pfizer’s total revenue for the second quarter was down 2% at $12.9bn.

Related news

Show more

Related product

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers